Exelixis
Manufacturing · 11-50 Employees
View Company Info for Free
Overview
Website
www.cometriq.comRevenue
<$5 MillionIndustry
About Exelixis
Is Exelixis your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Website visits: Recent activity has been detected on your website
Check if Exelixis has recently received funding, and reach out quickly before it becomes old news!
Click to see if Exelixis had a recent Job posting/layoffs
Product Launch: Get notified when Exelixis launches new products
Earning: See what the market has to say on Exelixis recently announced quarterly report
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Funding: Get notified immidiatlly once Exelixis has new funding data
Check out if Exelixis is spiking on competitors!
Congratulate Masked Content for being promoted to Masked Content at Exelixis
Exelixis, which may be a good buyer, showed buying intent in Masked Content Topic
Recommended Actions
Introduce yourself to Masked Content, who has shown a strong intent to purchase lately
Find more new buyers
Compare Similar Companies to Exelixis
Compare insights from companies similar to Exelixis, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Exelixis
Company Profile Activity
Activity Insights
Exelixis is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
Exelixis is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about Exelixis.
Exelixis Tech Stack
A closer look at the technologies used by Exelixis
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Exelixis
Founded in 1994, Exelixis, Inc. (Nasdaq: EXEL) is a commercially successful, oncology-focused biotechnology company that strives to accelerate the discovery, development and commercialization of new medicines for difficult-to-treat cancers.... Read More